• Biotinylated Human LILRA1 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
  • The purity of Biotinylated Human LILRA1 is greater than 95% as determined by SEC-HPLC.

Human LILRA1/CD85i/LIR-6 protein (Recombinant) (C-His-Avi) {Biotin} (STJP001689)

SKU:
STJP001689

Shipping:
Free Shipping
Current Stock:
Host: HEK293
Note: STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Recombinant-Human LILRA1/CD85i/LIR-6-C-His-Avi protein was developed from hek293 and has a target region of C-His-Avi. For use in research applications.
Conjugation: Biotin
Formulation: Lyophilised from 0.2 µm filtered PBS solution pH7.4.
Dilution Range: Upon receipt centrifuge vial to ensure maximal product extraction, recommended: 20sec, 5K RPM
Storage Instruction: The lyophilized protein is stable for at least 1 year from date of receipt at-20°C.
Endotoxin: Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg (1EU/µg).
Gene Symbol: LILRA1
Gene ID: 11024
Uniprot ID: LIRA1_HUMAN
Immunogen Region: Pro17-Asn461
Immunogen: DNA sequence encoding Human LILRA1/CD85i/LIR-6 including a C-His-Avi tag was expressed in HEK293 Cells. The recombinant protein was then biotinylated site specific using the AVItag biotinylation technology.
Function May act as receptor for class I MHC antigens.
Protein Name Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 1
Cd85 Antigen-Like Family Member I
Leukocyte Immunoglobulin-Like Receptor 6
Lir-6
Cd Antigen Cd85i
Database Links Reactome: R-HSA-198933
Cellular Localisation Membrane
Single-Pass Type I Membrane Protein
Alternative Protein Names Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 1 protein
Cd85 Antigen-Like Family Member I protein
Leukocyte Immunoglobulin-Like Receptor 6 protein
Lir-6 protein
Cd Antigen Cd85i protein
LILRA1 protein
LIR6 protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance